XTRA:SHLMedical Equipment
Learn Why The Bull Case For Siemens Healthineers Stock Could Change Following Liver Testing Partnership
Siemens Healthineers and Novo previously announced a collaboration to broaden non-invasive blood testing and awareness for MASLD and its progressive form MASH, aiming to reduce barriers to earlier disease assessment.
The tie-up directly targets growing demand for less invasive diagnostics in metabolic liver disease and reinforces Siemens Healthineers' focus on clinically integrated testing solutions that can strengthen its broader diagnostics portfolio.
We will now examine how this MASLD and...